Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chester Mays

Plastic Surgery Louisville, KY Medical Doctor

NPI 1689990624 CMS profile 2277414

2341 Lime Kiln Ln, Louisville, KY 40222

Open in the dashboard

General payments

$19,418

321 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chester Mays of Louisville, KY is reported in the CMS Open Payments database as having received $19,418 across 321 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,078 50
2024 General $1,503 44
2023 General $1,424 27
2022 General $3,920 66
2021 General $1,799 48
2020 General $924 39
2019 General $6,769 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chester Mays
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Chester Mays were reported at $3,078. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Chester Mays Plastic Surgery median Middle half National median
2019 $6,769 $371 $122–$1,483 $163
2020 $924 $158 $52–$438 $114
2021 $1,799 $249 $87–$752 $132
2022 $3,920 $274 $102–$793 $149
2023 $1,424 $299 $113–$891 $160
2024 $1,503 $361 $124–$1,062 $164
2025 $3,078 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sientra, Inc. $7,831 78 payments
  2. Allergan Inc. $2,104 82 payments
  3. Davol Inc. $1,904 16 payments
  4. Motiva USA, LLC $1,625 14 payments
  5. Merz North America, Inc. $1,221 17 payments
  6. RTI Surgical, Inc $892 7 payments
  7. AbbVie, Inc. $885 41 payments
  8. Tepha Inc $868 13 payments
  9. Revance Therapeutics, Inc. $631 20 payments
  10. Integra LifeSciences Corporation $597 10 payments
  11. Other $861 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,914 316 payments
  2. Consulting Fee $2,387 1 payment
  3. Travel and Lodging $703 2 payments
  4. Long term medical supply or device loan $326 1 payment
  5. Gift $87 1 payment
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $7,831 78 payments
  2. Motiva Implant Matrix $1,625 14 payments
  3. Phasix Mesh $1,055 9 payments
  4. GalaFLEX $868 13 payments
  5. CORTIVA ALLOGRAFT DERMIS $741 6 payments
  6. NATRELLE $730 19 payments
  7. DAXXIFY $631 20 payments
  8. DuraSorb Monofilament Mesh $514 6 payments
  9. NATRELLE SALINE-FILLED BREAST IMPLANTS $497 17 payments
  10. BOTOX $394 17 payments
  11. Other $2,611 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record